Vir Biotechnology Inc (VIR)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,150,380 | 1,240,730 | 1,433,670 | 1,547,360 | 1,590,240 | 1,675,080 | 1,810,210 | 1,970,760 | 2,077,960 | 2,149,860 | 1,952,010 | 2,001,010 | 1,431,850 | 876,274 | 737,325 | 650,951 | 716,852 | 812,355 | 563,779 | 380,333 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,150,380K)
= 0.00
The debt-to-capital ratio of Vir Biotechnology Inc has been consistently reported as 0.00 from March 31, 2020, through December 31, 2024. This indicates that the company has not reported any debt in relation to its capital during this period. A debt-to-capital ratio of 0.00 suggests that the company has not utilized debt financing as part of its capital structure or that any existing debt is negligible compared to its total capital. This could signal financial prudence, strong financial health, or a reliance on equity financing for its operations and growth. However, it is important to consider other financial metrics and factors to gain a comprehensive understanding of the company's overall financial strength and capital structure.
Peer comparison
Dec 31, 2024